GOLDMAN SACHS GROUP INC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 155 filers reported holding BLUEBIRD BIO INC in Q2 2022. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$2,312,753
-33.6%
760,774
-28.1%
0.00%
-100.0%
Q2 2023$3,482,821
-31.9%
1,058,608
-34.2%
0.00%0.0%
Q1 2023$5,112,680
-58.0%
1,607,761
-8.5%
0.00%
-66.7%
Q4 2022$12,165,637
+28.4%
1,758,040
+17.4%
0.00%
+50.0%
Q3 2022$9,476,000
+23.3%
1,497,063
-19.3%
0.00%0.0%
Q2 2022$7,684,000
-24.3%
1,855,880
-11.4%
0.00%0.0%
Q1 2022$10,155,000
-33.2%
2,093,824
+37.7%
0.00%
-33.3%
Q4 2021$15,192,000
-47.1%
1,520,751
+1.1%
0.00%
-50.0%
Q3 2021$28,732,000
-49.4%
1,503,532
-15.3%
0.01%
-53.8%
Q2 2021$56,755,000
+84.8%
1,774,700
+74.2%
0.01%
+62.5%
Q1 2021$30,715,000
-32.1%
1,018,737
-2.6%
0.01%
-27.3%
Q4 2020$45,238,000
+14.4%
1,045,485
+42.7%
0.01%0.0%
Q3 2020$39,538,000
-37.1%
732,864
-28.8%
0.01%
-42.1%
Q2 2020$62,866,000
+57.6%
1,029,909
+18.7%
0.02%
+35.7%
Q1 2020$39,894,000
-49.3%
868,015
-3.2%
0.01%
-30.0%
Q4 2019$78,664,000
+64.0%
896,460
+71.6%
0.02%
+42.9%
Q3 2019$47,958,000
-49.1%
522,309
-29.5%
0.01%
-48.1%
Q2 2019$94,301,000
-8.4%
741,363
+13.3%
0.03%
-12.9%
Q1 2019$102,961,000
+36.9%
654,424
-13.7%
0.03%
+29.2%
Q4 2018$75,204,000
+12.2%
758,103
+65.2%
0.02%
+41.2%
Q3 2018$67,011,000
-48.5%
458,980
-44.6%
0.02%
-51.4%
Q2 2018$130,098,000
+15.1%
828,916
+25.2%
0.04%
+20.7%
Q1 2018$113,019,000
+115.7%
661,899
+125.0%
0.03%
+123.1%
Q4 2017$52,385,000
+15.9%
294,134
-10.6%
0.01%
+30.0%
Q3 2017$45,199,000
-11.5%
329,076
-32.3%
0.01%
-23.1%
Q2 2017$51,045,000
+48.7%
485,912
+28.7%
0.01%
+30.0%
Q1 2017$34,319,000
+109.7%
377,548
+42.4%
0.01%
+100.0%
Q4 2016$16,364,000
-13.6%
265,208
-5.1%
0.01%
-16.7%
Q3 2016$18,935,000
+173.2%
279,355
+74.5%
0.01%
+200.0%
Q2 2016$6,930,000
-61.6%
160,086
-62.3%
0.00%
-66.7%
Q1 2016$18,056,000
-5.0%
424,860
+43.5%
0.01%0.0%
Q4 2015$19,012,000
-60.7%
296,034
-47.7%
0.01%
-62.5%
Q3 2015$48,423,000
-28.7%
566,021
+40.4%
0.02%
-23.8%
Q2 2015$67,887,000
+105.1%
403,206
+47.1%
0.02%
+90.9%
Q1 2015$33,097,000
-28.7%
274,050
-45.9%
0.01%
-26.7%
Q4 2014$46,434,000
+141.4%
506,252
-5.6%
0.02%
+114.3%
Q3 2014$19,234,000
+34.9%
536,077
+45.0%
0.01%
+40.0%
Q2 2014$14,257,000
+1780.9%
369,644
+922.6%
0.01%
Q4 2013$758,000
-3.7%
36,149
+23.9%
0.00%
Q3 2013$787,00029,1840.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,910,687$24,470,0003.71%
Monaco Asset Management SAM 306,142$1,267,0000.55%
Parametrica Management Ltd 90,105$374,0000.41%
Kamunting Street Capital Management, L.P. 55,200$229,0000.31%
Birchview Capital, LP 98,000$406,0000.30%
Kamunting Street Capital Management, L.P. 35,000$145,0000.20%
PDT Partners, LLC 519,477$2,151,0000.19%
Graham Capital Management, L.P. 781,912$3,237,0000.13%
CAXTON ASSOCIATES LP 220,154$911,0000.09%
Baker Brothers Advisors 2,499,715$10,349,0000.06%
View complete list of BLUEBIRD BIO INC shareholders